Literature DB >> 29411418

Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).

Najibah A Galadanci, Shehu Umar Abdullahi, Leah D Vance, Abdulkadir Musa Tabari, Shehi Ali, Raymond Belonwu, Auwal Salihu, Aisha Amal Galadanci, Binta Wudil Jibir, Halima Bello-Manga, Kathleen Neville, Fenella J Kirkham, Yu Shyr, Sharon Phillips, Brittany V Covert, Adetola A Kassim, Lori C Jordan, Muktar H Aliyu, Michael R DeBaun.   

Abstract

Entities:  

Year:  2018        PMID： 29411418     DOI： 10.1002/ajh.25012

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

1.  Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample.

Authors:  Richard Idro; Amelia K Boehme; Michael Kawooya; Samson K Lubowa; Deogratias Munube; Paul Bangirana; Robert Opoka; Ezekiel Mupere; Angela Lignelli; Philip Kasirye; Nancy S Green; Frank J Minja
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-02-11       Impact factor: 2.136

2.  Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.

Authors:  Shehu U Abdullahi; Binta J Wudil; Halima Bello-Manga; Aisha B Musa; Safiya Gambo; Najibah A Galadanci; Hauwa Aminu; Aliyu Tijjani Gaya; Surayya Sanusi; Musa A Tabari; Aisha Galadanci; Awwal Borodo; Muhammed S Abba; Abdu H Dambatta; Lawal Haliru; Awwal Gambo; Holly Cassell; Mark Rodeghier; Djamila L Ghafuri; Brittany V Covert Greene; Kathleen Neville; Adetola A Kassim; Fenella Kirkham; Edwin Trevathan; Lori C Jordan; Muktar H Aliyu; Michael R DeBaun
Journal:  Pediatr Hematol Oncol       Date:  2020-11-25       Impact factor: 1.969

3.  Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Authors:  Lise J Estcourt; Ruchika Kohli; Sally Hopewell; Marialena Trivella; Winfred C Wang
Journal:  Cochrane Database Syst Rev       Date:  2020-07-27

4.  Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria.

Authors:  Akinyemi O D Ofakunrin; Stephen Oguche; Kehinde Adekola; Edache S Okpe; Tolulope O Afolaranmi; Ijeoma N Diaku-Akinwumi; Ayuba I Zoakah; Atiene S Sagay
Journal:  J Trop Pediatr       Date:  2020-06-01       Impact factor: 1.165

5.  COVID-19 and SCA: an old friend comes to the rescue.

Authors:  Enrico M Novelli
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

6.  Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.

Authors:  Michael R DeBaun
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

7.  The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria.

Authors:  Muktar H Aliyu; Mahmoud U Sani; Donna J Ingles; Fatimah I Tsiga-Ahmed; Baba M Musa; Carolyn M Audet; C William Wester
Journal:  Health Res Policy Syst       Date:  2021-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.